PSUF
SRNE

People's United Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

People's United Financial’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$25K Hold
10,870
– – ﹤0.01% 617
2021
Q4 		$51K Hold
10,870
– – ﹤0.01% 669
2021
Q3 		$83K Buy
+10,870
New +$92.2K ﹤0.01% 718

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

People's United Financial's SRNE Position: Q1 2022 in Review

People's United Financial held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q1 2022 at 10,870 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #617.

People's United Financial first reported a position in SRNE in Q3 2021 and has held it in 3 quarters since. The position peaked at $83K in Q3 2021. 235 funds tracked by Wall St. Rank hold SRNE as of Q1 2022.

  • People's United Financial held 10,870 shares of Sorrento Therapeutics, Inc. worth $25K as of Q1 2022.
  • People's United Financial left its Sorrento Therapeutics, Inc. share count unchanged in Q1 2022.
  • Sorrento Therapeutics, Inc. made up ﹤0.01% of People's United Financial's portfolio in Q1 2022, its #617 holding.
  • People's United Financial first reported a position in Sorrento Therapeutics, Inc. in Q3 2021 and has held it in 3 quarters since.
  • People's United Financial's Sorrento Therapeutics, Inc. position peaked at $83K in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.